{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:29:59Z","timestamp":1786998599411,"version":"build-2736575974"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-143250"],"award-info":[{"award-number":["FDN-143250"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>TNF receptor\u2013associated factor 1 (TRAF1) is a prosurvival signaling adaptor that contributes to NF-\u03baB activation downstream of a subset of TNF receptor superfamily members. TRAF1 is overexpressed in many cancers of mature B cells, including chronic lymphocytic leukemia (CLL). Previous studies have established that TRAF1 S146 is a target of phosphorylation by the kinase PKN1 and that PKN1 is required to prevent cellular inhibitor of apoptosis protein (cIAP)\u2013dependent degradation of TRAF1 in the CD40 signaling complex. The kinase inhibitor OTSSP167 inhibits PKN1 in the nanomolar range and its addition to primary CLL cells was previously shown to induce dose-dependent loss of TRAF1 and concomitant increases in activated caspase 3 and cell death. These studies identified PKN1 as a target for therapy of CLL. To identify more potent and specific PKN1 inhibitors for therapy of B-cell cancers, it is important to measure a direct target of PKN1, such as phospho-TRAF1. To this end, here we use overexpression of an S146A mutant of human TRAF1 in HEK293 cells to validate a recently generated TRAF1 phospho (p)S146-specific antibody and to confirm that this phosphorylation is lost upon treatment with OTSSP167. Using CRISPR\/Cas9 knockout in RAJI cells, we also show that both PKN1 and the closely related family member PKN2 can phosphorylate TRAF1 S146. We further show that TRAF1 S146 is constitutively phosphorylated in OP9 cultured primary human CLL cells, including those with p53 mutations, and that this phosphorylation is sensitive to inhibition with OTSSP167. These findings provide support the development of more potent PKN1\/2 inhibitors for CLL.<\/jats:p>","DOI":"10.1093\/immhor\/vlag045","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:35:46Z","timestamp":1786995346000},"source":"Crossref","is-referenced-by-count":0,"title":["TRAF1 S146 is constitutively phosphorylated in OP9-cultured primary chronic lymphocytic leukemia cells by PKN1\/2"],"prefix":"10.1093","volume":"10","author":[{"given":"Birinder","family":"Ghumman","sequence":"first","affiliation":[{"name":"Department of Immunology, University of Toronto , Toronto, ON,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Nicolucci","sequence":"additional","affiliation":[{"name":"Muscle Health Research Centre, School of Kinesiology and Health Science, Faculty of Health, York University , Toronto, ON,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D","family":"Minden","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7897-4890","authenticated-orcid":false,"given":"Tania H","family":"Watts","sequence":"additional","affiliation":[{"name":"Department of Immunology, University of Toronto , Toronto, ON,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali A","family":"Abdul-Sater","sequence":"additional","affiliation":[{"name":"Muscle Health Research Centre, School of Kinesiology and Health Science, Faculty of Health, York University , Toronto, ON,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"2026081715354067400_vlag045-B1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41408-025-01434-2","article-title":"First-line treatment for CLL in the era of targeted therapy","volume":"16","author":"Davids","year":"2026","journal-title":"Blood Cancer J"},{"key":"2026081715354067400_vlag045-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428194.2017.1283032","article-title":"Pathways and mechanisms of venetoclax resistance","volume":"58","author":"Bose","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"2026081715354067400_vlag045-B3","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.3389\/fimmu.2018.02969","article-title":"TRAF1 signaling in human health and disease","volume":"9","author":"Edilova","year":"2018","journal-title":"Front Immunol"},{"key":"2026081715354067400_vlag045-B4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3389\/fimmu.2019.00104","article-title":"The evolving role of TRAFs in mediating inflammatory responses","volume":"10","author":"Dhillon","year":"2019","journal-title":"Front Immunol"},{"key":"2026081715354067400_vlag045-B5","doi-asserted-by":"crossref","first-page":"5084","DOI":"10.4049\/jimmunol.165.9.5084","article-title":"TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies","volume":"165","author":"Zapata","year":"2000","journal-title":"J Immunol"},{"key":"2026081715354067400_vlag045-B6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1182\/blood-2006-11-058446","article-title":"NF-kappaB2 mutation targets TRAF1 to induce lymphomagenesis","volume":"110","author":"Zhang","year":"2007","journal-title":"Blood"},{"key":"2026081715354067400_vlag045-B7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.molcel.2010.03.009","article-title":"Crystal structures of the TRAF2:cIAP2 and the TRAF1:TRAF2:cIAP2 complexes: affinity, specificity, and regulation","volume":"38","author":"Zheng","year":"2010","journal-title":"Mol Cell"},{"key":"2026081715354067400_vlag045-B8","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1084\/jem.20020774","article-title":"Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling","volume":"196","author":"Arron","year":"2002","journal-title":"J Exp Med"},{"key":"2026081715354067400_vlag045-B9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1128\/MCB.17.3.1535","article-title":"Induction of nuclear factor kappaB by the CD30 receptor is mediated by TRAF1 and TRAF2","volume":"17","author":"Duckett","year":"1997","journal-title":"Mol Cell Biol"},{"key":"2026081715354067400_vlag045-B10","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1126\/science.281.5383.1680","article-title":"NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation","volume":"281","author":"Wang","year":"1998","journal-title":"Science"},{"key":"2026081715354067400_vlag045-B11","doi-asserted-by":"crossref","first-page":"23010","DOI":"10.1074\/jbc.M112.350538","article-title":"Opposing roles for TRAF1 in the alternative versus classical NF-\u03baB pathway in T cells","volume":"287","author":"McPherson","year":"2012","journal-title":"J Biol Chem"},{"key":"2026081715354067400_vlag045-B12","doi-asserted-by":"crossref","first-page":"5388","DOI":"10.4049\/jimmunol.176.9.5388","article-title":"Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling","volume":"176","author":"Xie","year":"2006","journal-title":"J Immunol"},{"key":"2026081715354067400_vlag045-B13","doi-asserted-by":"crossref","first-page":"1943234","DOI":"10.1080\/2162402X.2021.1943234","article-title":"The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia","volume":"10","author":"Edilova","year":"2021","journal-title":"Oncoimmunology"},{"key":"2026081715354067400_vlag045-B14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2443.2008.01182.x","article-title":"Negative regulation of constitutive NF-kappaB and JNK signaling by PKN1-mediated phosphorylation of TRAF1","volume":"13","author":"Kato","year":"2008","journal-title":"Genes Cells"},{"key":"2026081715354067400_vlag045-B15","doi-asserted-by":"crossref","first-page":"5520","DOI":"10.1038\/s41388-018-0333-x","article-title":"Inhibition of maternal embryonic leucine zipper kinase with OTSSP167 displays potent anti-leukemic effects in chronic lymphocytic leukemia","volume":"37","author":"Zhang","year":"2018","journal-title":"Oncogene"},{"key":"2026081715354067400_vlag045-B16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0014-5793(99)01356-3","article-title":"TRAF1 is a TNF inducible regulator of NF-kappaB activation","volume":"460","author":"Carpentier","year":"1999","journal-title":"FEBS Lett"},{"key":"2026081715354067400_vlag045-B17","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BST20200466","article-title":"The structure and function of protein kinase C-related kinases (PRKs)","volume":"49","author":"Sophocleous","year":"2021","journal-title":"Biochem Soc Trans"},{"key":"2026081715354067400_vlag045-B18","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gky354","article-title":"CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens","volume":"46","author":"Concordet","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2026081715354067400_vlag045-B19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nmeth.3047","article-title":"Improved vectors and genome-wide libraries for CRISPR screening","volume":"11","author":"Sanjana","year":"2014","journal-title":"Nat Methods"},{"key":"2026081715354067400_vlag045-B20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat Biotechnol"},{"key":"2026081715354067400_vlag045-B21","doi-asserted-by":"crossref","first-page":"7913","DOI":"10.1038\/sj.onc.1208929","article-title":"Constitutive activation of the CD40 pathway promotes cell transformation and neoplastic growth","volume":"24","author":"Baxendale","year":"2005","journal-title":"Oncogene"},{"key":"2026081715354067400_vlag045-B22","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1038\/sj.onc.1205337","article-title":"Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells","volume":"21","author":"Horie","year":"2002","journal-title":"Oncogene"},{"key":"2026081715354067400_vlag045-B23","doi-asserted-by":"crossref","first-page":"1371057","DOI":"10.3389\/fonc.2024.1371057","article-title":"An overview of prognostic markers in patients with CLL","volume":"14","author":"Braish","year":"2024","journal-title":"Front Oncol"}],"container-title":["ImmunoHorizons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/10\/8\/vlag045\/70671760\/vlag045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article-pdf\/10\/8\/vlag045\/70671760\/vlag045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:35:49Z","timestamp":1786995349000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/immunohorizons\/article\/doi\/10.1093\/immhor\/vlag045\/8762854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,4]]}},"URL":"https:\/\/doi.org\/10.1093\/immhor\/vlag045","relation":{},"ISSN":["2573-7732"],"issn-type":[{"value":"2573-7732","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,8]]},"published":{"date-parts":[[2026,8]]},"article-number":"vlag045"}}